Altimmune, Inc. (NASDAQ: ALT) Investors Advised by Berger Montague: Deadline Approaching

Altimmune, Inc. (NASDAQ: ALT) investors are being reminded by Berger Montague of an approaching deadline in the securities fraud lawsuit. The deadline for investors to take action is approaching, and it is important for those affected to be aware of their rights in this matter.

The lawsuit against Altimmune, Inc. alleges that the company failed to disclose certain information to investors, which ultimately led to a decline in the stock price. This lack of disclosure is seen as a violation of federal securities laws, and investors who suffered losses as a result may be entitled to compensation.

Investors who purchased Altimmune, Inc. securities between May 18, 2018, and May 19, 2021, are encouraged to contact Berger Montague before the upcoming deadline to discuss their options. It is crucial for investors to act quickly in order to protect their rights and potentially recover losses incurred due to the alleged securities fraud.

Berger Montague is a national law firm that has been involved in numerous securities fraud cases, representing investors who have been impacted by deceptive practices in the market. The firm has a team of experienced attorneys who are dedicated to helping investors seek justice and recover losses caused by fraudulent behavior.

Investors who believe they may have a claim in the Altimmune, Inc. securities fraud lawsuit are urged to contact Berger Montague as soon as possible. The firm offers a free consultation to discuss the details of the case and determine the best course of action for those affected by the alleged fraud.

In conclusion, Altimmune, Inc. investors should be aware of the approaching deadline in the securities fraud lawsuit and take action to protect their rights. Berger Montague is available to provide guidance and legal representation to investors who may have suffered losses due to the alleged misconduct of the company. By seeking legal counsel, investors can work towards recovering losses and holding those responsible for the alleged fraud accountable for their actions.